Total Payments
$196,519
2024 Payments
$119,736
Companies
10
Transactions
241
Medicare Patients
7,573
Medicare Billing
$1.0M

Payment Breakdown by Category

Other$147,672 (75.1%)
Consulting$23,473 (11.9%)
Travel$19,273 (9.8%)
Food & Beverage$6,071 (3.1%)
Education$29.99 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $147,672 54 75.1%
Consulting Fee $23,473 5 11.9%
Travel and Lodging $19,273 80 9.8%
Food and Beverage $6,071 101 3.1%
Education $29.99 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Neurocrine Biosciences, Inc. $166,845 184 $0 (2024)
Otsuka America Pharmaceutical, Inc. $23,461 35 $0 (2024)
E.R. Squibb & Sons, L.L.C. $5,920 12 $0 (2024)
ACADIA Pharmaceuticals Inc $121.84 1 $0 (2024)
Teva Pharmaceuticals USA, Inc. $55.84 3 $0 (2023)
Otsuka Pharmaceutical Development & Commercialization, Inc. $37.96 2 $0 (2024)
Allergan Inc. $29.99 1 $0 (2018)
Alkermes, Inc. $17.78 1 $0 (2018)
Avanir Pharmaceuticals, Inc. $15.48 1 $0 (2022)
Amarin Pharma Inc. $13.76 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $119,736 153 Neurocrine Biosciences, Inc. ($90,516)
2023 $76,292 76 Neurocrine Biosciences, Inc. ($76,011)
2022 $258.45 7 Neurocrine Biosciences, Inc. ($217.25)
2019 $84.58 2 Otsuka America Pharmaceutical, Inc. ($70.82)
2018 $148.09 3 Neurocrine Biosciences, Inc. ($100.32)

All Payment Transactions

241 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/05/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,625.00 General
Category: Neuropsychiatry
12/05/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $123.04 General
Category: Neuropsychiatry
11/25/2024 E.R. Squibb & Sons, L.L.C. Travel and Lodging Cash or cash equivalent $50.00 General
11/14/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,563.00 General
Category: Neuropsychiatry
11/14/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,625.00 General
Category: Neuropsychiatry
11/14/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Travel and Lodging In-kind items and services $499.12 General
Category: Neuropsychiatry
11/14/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Travel and Lodging In-kind items and services $212.96 General
Category: Neuropsychiatry
11/14/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Travel and Lodging In-kind items and services $190.12 General
Category: Neuropsychiatry
11/14/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $117.46 General
Category: Neuropsychiatry
11/14/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Travel and Lodging In-kind items and services $67.86 General
Category: Neuropsychiatry
11/14/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Travel and Lodging In-kind items and services $50.00 General
Category: Neuropsychiatry
11/14/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Travel and Lodging In-kind items and services $25.18 General
Category: Neuropsychiatry
11/14/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $15.93 General
Category: Neuropsychiatry
10/31/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,742.00 General
Category: PSYCHIATRY
10/24/2024 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Food and Beverage In-kind items and services $121.84 General
Category: PARKINSONS DISEASE PSYCHOSIS
10/23/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $125.00 General
Category: PSYCHIATRY
10/22/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $144.51 General
Category: Neuropsychiatry
10/17/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $16.11 General
Category: Psychiatry/Psychology
10/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,563.00 General
Category: Neuropsychiatry
10/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,625.00 General
Category: Neuropsychiatry
10/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Travel and Lodging In-kind items and services $980.12 General
Category: Neuropsychiatry
10/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Travel and Lodging In-kind items and services $473.95 General
Category: Neuropsychiatry
10/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Travel and Lodging In-kind items and services $437.03 General
Category: Neuropsychiatry
10/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Neuropsychiatry
10/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Travel and Lodging In-kind items and services $50.00 General
Category: Neuropsychiatry

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 2,128 3,314 $603,960 $297,720
2022 8 2,172 3,308 $620,846 $250,268
2021 7 1,671 2,729 $641,239 $253,339
2020 9 1,602 2,432 $570,700 $223,787
Total Patients
7,573
Total Services
11,783
Medicare Billing
$1.0M
Procedure Codes
30

All Medicare Procedures & Services

30 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Facility 2023 883 1,878 $319,260 $163,340 51.2%
99305 Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes Facility 2023 600 602 $144,480 $66,973 46.4%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Facility 2023 438 616 $80,080 $37,404 46.7%
99310 Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 113 124 $31,000 $15,881 51.2%
99306 Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 94 94 $29,140 $14,121 48.5%
99309 Follow-up nursing facility visit per day, typically 25 minutes Facility 2022 726 1,462 $257,936 $99,442 38.6%
99305 Initial nursing facility visit per day, typically 35 minutes Facility 2022 528 528 $126,720 $56,655 44.7%
99308 Follow-up nursing facility visit per day, typically 15 minutes Facility 2022 464 771 $100,230 $44,642 44.5%
99306 Initial nursing facility visit per day, typically 45 minutes Facility 2022 160 160 $48,768 $19,747 40.5%
99310 Follow-up nursing facility visit per day, typically 35 minutes Facility 2022 136 154 $39,004 $16,407 42.1%
99335 Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes Office 2022 92 166 $35,195 $9,255 26.3%
99334 Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes Office 2022 53 54 $9,288 $2,729 29.4%
99326 New patient custodial care facility, group care, or assisted living visit, typically 45 minutes Office 2022 13 13 $3,705 $1,390 37.5%
99309 Subsequent nursing facility visit, typically 25 minutes per day Facility 2021 634 1,433 $295,198 $105,494 35.7%
99306 Initial nursing facility visit, typically 45 minutes per day Facility 2021 685 704 $212,608 $98,496 46.3%
99335 Established patient assisted living visit, typically 25 minutes Office 2021 114 327 $69,331 $24,244 35.0%
99310 Subsequent nursing facility visit, typically 35 minutes per day Facility 2021 144 167 $43,253 $19,211 44.4%
99308 Subsequent nursing facility visit, typically 15 minutes per day Facility 2021 60 64 $11,584 $2,790 24.1%
99326 New patient assisted living visit, typically 45 minutes Office 2021 17 17 $4,845 $1,769 36.5%
99305 Initial nursing facility visit, typically 35 minutes per day Facility 2021 17 17 $4,420 $1,334 30.2%
99309 Subsequent nursing facility visit, typically 25 minutes per day Facility 2020 506 1,161 $239,166 $84,283 35.2%
99306 Initial nursing facility visit, typically 45 minutes per day Facility 2020 549 560 $169,120 $76,514 45.2%
99336 Established patient assisted living visit, typically 40 minutes Office 2020 117 238 $61,166 $23,566 38.5%
99310 Subsequent nursing facility visit, typically 35 minutes per day Facility 2020 80 96 $24,864 $11,089 44.6%
99309 Subsequent nursing facility visit, typically 25 minutes per day Office 2020 87 91 $18,746 $7,102 37.9%

About Dr. Erik Cabrera, M.D

Dr. Erik Cabrera, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1003200395.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erik Cabrera, M.D has received a total of $196,519 in payments from pharmaceutical and medical device companies, with $119,736 received in 2024. These payments were reported across 241 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($147,672).

As a Medicare-enrolled provider, Cabrera has provided services to 7,573 Medicare beneficiaries, totaling 11,783 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.

Practice Information

Products in Payments

  • INGREZZA (Drug) $166,825
  • REXULTI (Drug) $23,374
  • NUEDEXTA (Drug) $124.99
  • NUPLAZID (Drug) $121.84
  • AUSTEDO (Drug) $55.84
  • VRAYLAR (Drug) $29.99
  • Ongentys (Drug) $20.33
  • Aristada 441 mg (Drug) $17.78
  • COBENFY (Drug) $16.11
  • Nuedexta (Drug) $15.48
  • Vascepa (Drug) $13.76

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Miami